| Biomarker ID | 887 |
| PMID | 22397815 |
| Year | 2012 |
| Biomarker | kallikrein-related peptide 4 (KLK4) |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Downregulated in genistein treated patients compared to placebo treated |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Treated with Placebo Vs Treated with Genistein (30mg capsule) |
| Type of Biomarker | Predictive |
| Cohort | 47 Norwegian patients were selected and randomly given placebo or genistein. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.033 |
| Method Used | real-time semiquantitative PCR |
| Clinical | Yes |
| Remarks | NA |
| Clinical Trial Number | NCT00546039 |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | KLK4 |